<h4>Introduction</h4>Thrombotic thrombocytopenic purpura (TTP) is a rare, life-threatening thrombotic microangiopathy due to an acquired autoantibody to ADAMTS13 that requires a boutique treatment, urgent plasma exchange. This evidence concerns the gene ADAMTS13 and Genetic thrombotic microangiopathy.